Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             72 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute promyelocytic leukemia: What is the new standard of care? Watts, Justin M.
2014
5 p. 205-212
8 p.
artikel
2 Anti-CD20 monoclonal antibodies: Beyond B-cells Avivi, Irit
2013
5 p. 217-223
7 p.
artikel
3 Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research Di Minno, Alessandro
2015
5 p. 335-343
9 p.
artikel
4 An update of the mutation profile of Factor 13 A and B genes Biswas, Arijit
2011
5 p. 193-204
12 p.
artikel
5 Approach to pancytopenia: Diagnostic algorithm for clinical hematologists Gnanaraj, Jerome
2018
5 p. 361-367
artikel
6 Autophagy: A necessary event during erythropoiesis Grosso, Rubén
2017
5 p. 300-305
6 p.
artikel
7 Autophagy as a target for hematological malignancy therapy Dong, Zhiwu
2016
5 p. 369-380
12 p.
artikel
8 Basic mechanisms and pathogenesis of venous thrombosis Esmon, Charles T.
2009
5 p. 225-229
5 p.
artikel
9 Biomechanics of lower limb haemophilic arthropathy Stephensen, David
2012
5 p. 213-221
9 p.
artikel
10 Bleeding in the heritable connective tissue disorders: Mechanisms, diagnosis and treatment Malfait, Fransiska
2009
5 p. 191-197
7 p.
artikel
11 Blood flow and mass transfer regulation of coagulation Rana, Kuldeepsinh
2016
5 p. 357-368
12 p.
artikel
12 Catalyzing improvements in ALL therapy with asparaginase Marini, Bernard L.
2017
5 p. 328-338
11 p.
artikel
13 Cereblon binding molecules in multiple myeloma Kortüm, K.M.
2015
5 p. 329-334
6 p.
artikel
14 Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections Hilal, Talal
2018
5 p. 387-399
artikel
15 Chronic myelomoncytic leukemia: Are we finally solving the identity crisis? Nazha, Aziz
2016
5 p. 381-388
8 p.
artikel
16 Current therapy of myelodysplastic syndromes Zeidan, Amer M.
2013
5 p. 243-259
17 p.
artikel
17 Dancing partners at the ball: Rational selection of next generation anti-CD20 antibodies for combination therapy of chronic lymphocytic leukemia in the novel agents era Butler, L.A.
2017
5 p. 318-327
10 p.
artikel
18 Does percutaneous coronary stent implantation increase platelet reactivity? Janssen, P.W.A.
2017
5 p. 271-275
5 p.
artikel
19 Editorial Board 2009
5 p. i-
1 p.
artikel
20 Emerging options in the treatment of deep vein thrombosis and pulmonary embolism Brenner, Benjamin
2011
5 p. 215-221
7 p.
artikel
21 Emerging therapies for patients with advanced chronic lymphocytic leukaemia Delgado, Julio
2009
5 p. 217-224
8 p.
artikel
22 Extramedullary acute myelogenous leukemia Solh, Melhem
2016
5 p. 333-339
7 p.
artikel
23 Front-line therapy in polycythemia vera and essential thrombocythemia Barbui, Tiziano
2012
5 p. 205-211
7 p.
artikel
24 G6PD deficiency: the genotype-phenotype association Mason, Philip J
2007
5 p. 267-283
17 p.
artikel
25 Haemoglobinopathy diagnosis: Algorithms, lessons and pitfalls Bain, Barbara J.
2011
5 p. 205-213
9 p.
artikel
26 Haemophilia gene therapy: Progress and challenges Lheriteau, Elsa
2015
5 p. 321-328
8 p.
artikel
27 Hairy cell leukemia: Update on molecular profiling and therapeutic advances Grever, Michael R.
2014
5 p. 197-203
7 p.
artikel
28 Hemophagocytic syndromes Janka, Gritta E.
2007
5 p. 245-253
9 p.
artikel
29 How I treat acute and chronic leukemia in pregnancy Shapira, Tal
2008
5 p. 247-259
13 p.
artikel
30 Immunodeficiency-associated lymphomas Tran, Huy
2008
5 p. 261-281
21 p.
artikel
31 Immunotherapeutic strategies for relapse control in acute myeloid leukemia Martner, Anna
2013
5 p. 209-216
8 p.
artikel
32 Infections associated with purine analogs and monoclonal antibodies Ravandi, Farhad
2005
5 p. 253-273
21 p.
artikel
33 Information transfer by exosomes: A new frontier in hematologic malignancies Boyiadzis, Michael
2015
5 p. 281-290
10 p.
artikel
34 Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications Arranz, Lorena
2017
5 p. 306-317
12 p.
artikel
35 Ironing out the details of iron overload in myelofibrosis: Lessons from myelodysplastic syndromes Carreau, Nicole
2016
5 p. 349-356
8 p.
artikel
36 JAK inhibitors in myeloproliferative neoplasms: Rationale, current data and perspective Tefferi, A.
2011
5 p. 229-237
9 p.
artikel
37 Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy Griesshammer, Martin
2008
5 p. 235-245
11 p.
artikel
38 Molecular biology of mantle cell lymphoma: From profiling studies to new therapeutic strategies Obrador-Hevia, Antònia
2009
5 p. 205-216
12 p.
artikel
39 Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma Rajkumar, S. Vincent
2007
5 p. 255-265
11 p.
artikel
40 Musculo-skeletal manifestations of haemophilia Rodriguez-Merchan, E. Carlos
2016
5 p. 401-409
9 p.
artikel
41 Myeloid-derived suppressor cells: The green light for myeloma immune escape Malek, Ehsan
2016
5 p. 341-348
8 p.
artikel
42 New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies Leather, Helen L.
2006
5 p. 267-287
21 p.
artikel
43 Non-Hodgkin lymphomas in pregnancy: Tackling therapeutic quandaries Avivi, Irit
2014
5 p. 213-220
8 p.
artikel
44 Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome Burks, Eric J.
2006
5 p. 245-266
22 p.
artikel
45 Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemia Mathisen, Michael S.
2014
5 p. 179-187
9 p.
artikel
46 Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI Wight, Joel C.
2018
5 p. 400-415
artikel
47 Radioimmunotherapy-based conditioning for hematopoietic stem cell transplantation: Another step forward Ali, Alaa M.
2016
5 p. 389-399
11 p.
artikel
48 Risk-adapted therapy in essential thrombocythemia and polycythemia vera Finazzi, Guido
2005
5 p. 243-252
10 p.
artikel
49 Should studies on Glanzmann thrombasthenia not be telling us more about cardiovascular disease and other major illnesses? Nurden, Alan T.
2017
5 p. 287-299
13 p.
artikel
50 Standing up to the cardiometabolic consequences of hematological cancers Howden, Erin J.
2018
5 p. 349-360
artikel
51 Stem cell transplantation for indolent lymphoma van Besien, Koen
2011
5 p. 223-228
6 p.
artikel
52 Strategies targeting apoptosis proteins to improve therapy of chronic lymphocytic leukemia Besbes, Samaher
2015
5 p. 345-350
6 p.
artikel
53 Thalassemia and hypercoagulability Taher, Ali T.
2008
5 p. 283-292
10 p.
artikel
54 The bone marrow microenvironment – Home of the leukemic blasts Shafat, Manar S
2017
5 p. 277-286
10 p.
artikel
55 The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma Van Besien, Koen
2006
5 p. 235-244
10 p.
artikel
56 The future of JAK inhibition in myelofibrosis and beyond Mascarenhas, John O.
2014
5 p. 189-196
8 p.
artikel
57 The molecular physiology and pathology of fibrin structure/function Standeven, Kristina F.
2005
5 p. 275-288
14 p.
artikel
58 The possible role of maintenance treatment for primary central nervous system lymphoma Bairey, Osnat
2018
5 p. 378-386
artikel
59 Therapy of Relapsed Hodgkin Lymphoma Cashen, Amanda F.
2007
5 p. 233-243
11 p.
artikel
60 The roles of JAK2 in DNA damage and repair in the myeloproliferative neoplasms: Opportunities for targeted therapy Karantanos, Theodoros
2018
5 p. 426-432
artikel
61 Thrombin generation: What have we learned? Al Dieri, Raed
2012
5 p. 197-203
7 p.
artikel
62 Thrombotic complications associated with stem cell transplantation Nadir, Yona
2012
5 p. 183-187
5 p.
artikel
63 Time to repeal and replace response criteria for acute myeloid leukemia? Bloomfield, Clara Derber
2018
5 p. 416-425
artikel
64 To chelate or not to chelate in MDS: That is the question! Zeidan, Amer M.
2018
5 p. 368-377
artikel
65 To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity Hartholt, Robin B.
2017
5 p. 339-347
9 p.
artikel
66 Transfusions for anemia in adult and pediatric patients with malignancies Shah, Neil
2015
5 p. 291-299
9 p.
artikel
67 Transfusion strategies for traumatic coagulopathy Curry, Nicola S.
2012
5 p. 223-232
10 p.
artikel
68 Travel and thrombosis Watson, Henry G.
2005
5 p. 235-241
7 p.
artikel
69 Umbilical cord blood transplantation: Pros, cons and beyond Stanevsky, Anfisa
2009
5 p. 199-204
6 p.
artikel
70 Vena cava filters for management of venous thromboembolism: A clinical review Rajasekhar, Anita
2013
5 p. 225-241
17 p.
artikel
71 Von Willebrand factor deficiency and atherosclerosis van Galen, K.P.M.
2012
5 p. 189-196
8 p.
artikel
72 Waldenström macroglobulinemia: What a hematologist needs to know Kapoor, Prashant
2015
5 p. 301-319
19 p.
artikel
                             72 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland